A carregar...

Variation in Serum PCSK9, Cardiovascular Disease Risk and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition: A GWAS and Mendelian Randomization Study in the Nord-Trøndelag Health Study, Norway

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Genom Precis Med
Main Authors: Brumpton, Ben M., Fritsche, Lars G., Zheng, Jie, Nielsen, Jonas Bille, Mannila, Maria, Surakka, Ida, Rasheed, Humaira, Vie, Gunnhild Åberge, Graham, Sarah E., Gabrielsen, Maiken Elvestad, Laugsand, Lars Erik, Aukrust, Pål, Vatten, Lars Johan, Damås, Jan Kristian, Ueland, Thor, Janszky, Imre, Zwart, John-Anker, van ´t Hooft, Ferdinand M., Seidah, Nabil Georges, Hveem, Kristian, Willer, Cristen, Smith, George Davey, Åsvold, Bjørn Olav
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6530796/
https://ncbi.nlm.nih.gov/pubmed/30645169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.118.002335
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!